This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Dividendos de 1Life Healthcare

Dividendo controles de criterios 0/6

Información clave

n/a

Rentabilidad por dividendo

n/a

Ratio de pago

Rentabilidad media de la industria	1.7%
Próxima fecha de pago de dividendos	n/a
Fecha ex dividendo	n/a
Dividendo por acción	n/a
Beneficios por acción	-US$1.93
Rentabilidad por dividendo prevista a 3 años	0%

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

1Life Healthcare, Inc. (NASDAQ:ONEM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$54.00

Feb 28

Can You Imagine How Jubilant 1Life Healthcare's (NASDAQ:ONEM) Shareholders Feel About Its 129% Share Price Gain?

Feb 01

1Life Healthcare Sets Foundation For Future Growth

Dec 31

Are Insiders Selling 1Life Healthcare, Inc. (NASDAQ:ONEM) Stock?

Dec 18

1Life Healthcare Q3 2020 Earnings Preview

Nov 09

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Insufficient data to determine if ONEM's dividends per share have been stable in the past.

Dividendo creciente: Insufficient data to determine if ONEM's dividend payments have been increasing.

Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de 1Life Healthcare vs. Mercado

¿Cómo se compara la rentabilidad por dividendo de ONEM con la del mercado?
Segmento	Rentabilidad por dividendo
Empresa (ONEM)	n/a
Suelo de mercado 25% (US)	1.5%
Techo de mercado 25% (US)	4.7%
Media de la industria (Healthcare)	1.7%
Previsión de analistas en 3 años (ONEM)	0%

Dividendo destacado: Unable to evaluate ONEM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Alto dividendo: Unable to evaluate ONEM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Pago de beneficios a los accionistas

Cobertura de los beneficios: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Pago en efectivo a los accionistas

Cobertura de flujo de caja: Unable to calculate sustainability of dividends as ONEM has not reported any payouts.

This company has been acquired

Dividendos de 1Life Healthcare

Dividendo controles de criterios 0/6

Información clave

Últimas actualizaciones de dividendos

Recent updates

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

General Counsel & Corporate Secretary exercised options and sold US$211k worth of stock

Forecast to breakeven in 2025

General Counsel & Corporate Secretary exercised options and sold US$155k worth of stock

CFO & Principal Financial Officer exercised options and sold US$96k worth of stock

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Amazon receives FTC request for more information about One Medical deal

1Life Healthcare: Amazon Merger Unlikely To Face Regulatory Pushback

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Amazon.com, Inc. (NasdaqGS:AMZN) entered into a definitive merger agreement to acquire 1Life Healthcare, Inc. (NasdaqGS:ONEM) for approximately $3.7 billion.

Amazon.com, Inc. (NasdaqGS:AMZN) entered into a definitive merger agreement to acquire 1Life Healthcare, Inc. (NasdaqGS:ONEM) for approximately $3.6 billion.

Price target increased to US$15.43

1Life Healthcare, Inc. Appoints Vikas Agarwal as Chief Accounting Officer and Principal Accounting Officer

1Life Healthcare jumps after report of takeover interest

1Life Healthcare, Inc.(NasdaqGS:ONEM) dropped from Russell 2000 Growth Index

Is 1Life Healthcare (NASDAQ:ONEM) A Risky Investment?

Price target decreased to US$13.85

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

1Life Healthcare, Inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2022 and for the Year Ending December 31, 2022

High number of new directors

1Life Healthcare, Inc., Annual General Meeting, Jun 02, 2022

Price target decreased to US$15.31

Is 1Life Healthcare (NASDAQ:ONEM) Weighed On By Its Debt Load?

Full year 2021 earnings: EPS and revenues exceed analyst expectations

1Life Healthcare, Inc. Provides Revenue Guidance for the Three and Twelve Months Ending December 31, 2022

1Life Healthcare, Inc. to Report Q4, 2021 Results on Feb 23, 2022

1Life Healthcare: Not So Healthy Heading Into 2022

Price target decreased to US$30.57

Chair, CEO & President exercised options to buy US$1.5m worth of stock.

Does 1Life Healthcare (NASDAQ:ONEM) Have A Healthy Balance Sheet?

Price target decreased to US$33.15

Third quarter 2021 earnings released: US$0.51 loss per share (vs US$0.13 loss in 3Q 2020)

High number of new directors

Price target decreased to US$35.69

High number of new directors

1Life Healthcare: Post-Merger Earnings Preview

Price target decreased to US$38.62

1Life Healthcare, Inc. (NasdaqGS:ONEM) completed the acquisition of Iora Health, Inc. from Temasek Holdings (Private) Limited and others.

1Life Healthcare: Why We Are Against The Merger

Consensus forecasts updated

Price target decreased to US$43.45

1Life Healthcare, Inc. Provides Earnings and Operating Guidance for the Third Quarter and Year 2021

Second quarter 2021 earnings released: US$0.30 loss per share (vs US$0.24 loss in 2Q 2020)

High number of new directors

Independent Director notifies of intention to sell stock

1Life Healthcare: Some Questions After Recent Events

Independent Director David Singer has left the company

Consensus forecasts updated

Price target decreased to US$51.50

Consensus forecasts updated

Forecast to breakeven in 2023

First quarter 2021 earnings released: US$0.29 loss per share (vs US$0.40 loss in 1Q 2020)

1Life Healthcare, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2021

Health Check: How Prudently Does 1Life Healthcare (NASDAQ:ONEM) Use Debt?

Independent Director notifies of intention to sell stock

General Counsel & Corporate Secretary exercised options and sold US$365k worth of stock

Full year 2020 earnings released: US$0.75 loss per share (vs US$2.84 loss in FY 2019)

Price target raised to US$54.00

1Life Healthcare, Inc. (NASDAQ:ONEM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$54.00

Price target raised to US$51.89

Full year 2020 earnings released: US$0.75 loss per share (vs US$2.84 loss in FY 2019)

Revenue beats expectations, earnings disappoint

1Life Healthcare, Inc. to Report Q4, 2020 Results on Feb 25, 2021

New 90-day high: US$55.03

Can You Imagine How Jubilant 1Life Healthcare's (NASDAQ:ONEM) Shareholders Feel About Its 129% Share Price Gain?

New 90-day high: US$47.71

Chair, CEO & President notifies of intention to sell stock

One Medical Begins Administering Vaccinations for Phase 1A Populations Who Work or Live in San Francisco

New 90-day high: US$43.65

1Life Healthcare Sets Foundation For Future Growth

Are Insiders Selling 1Life Healthcare, Inc. (NASDAQ:ONEM) Stock?

Chief Financial Officer notifies of intention to sell stock

New 90-day high: US$36.14

Analysts increase EPS estimates to -US$0.87